Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
PHARMASEAL Logo
PHARMASEAL Growth Score
63
CB Rank
128470
Heat Score
48
PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
Founded
obfuscation
PrivateEquity Crowdfunding Nottingham, Nottingham, United Kingdom11-50 www.pharmaseal.co/
Biopharma
Health Care
Pharmaceutical
Overview

PHARMASEAL
Total Funding
obfuscation
Growth Score
63
Heat Score
48

Total Funding
obfuscation
obfuscation
Equity Crowdfunding raised
obfuscation
Growth Score63
-13 pts
in past quarter
Heat Score 48
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About PHARMASEAL

CB Rank
128470
PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
Founded
obfuscation
PrivateEquity Crowdfunding Nottingham, Nottingham, United Kingdom11-50 www.pharmaseal.co/
Biopharma
Health Care
Pharmaceutical

Funding Rounds

Equity Crowdfunding
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name PHARMASEAL International Limited
Operating Status Active
Company Type For Profit
Founders  Daljit Cheema
About the Company
PHARMASEAL was born in 2016 with the mission to create a digital platform that enables their customers to increase control of their clinical trials and accelerate product development. PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
Phone Number +44(0)1157486712
Contact Email info@pharmaseal.co
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Engility® CTMS
A cloud-based clinical trial management system designed to unify trial governance and oversight for biopharmaceutical and related companies.
Engility® eTMF
An electronic Trial Master File system integrated with Engility® CTMS for centralized management and compliance of clinical trial documentation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding
obfuscation
Equity Crowdfunding - PHARMASEAL Logo
Equity Crowdfunding - PHARMASEAL
—
obfuscation
— Equity Crowdfunding

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Mercia Fund Managers Logo
Mercia Fund Managers
—
Series A - PHARMASEAL Logo
Series A - PHARMASEAL
—
Mercia Fund Managers Logo
Mercia Fund Managers
—
Series A - PHARMASEAL Logo
Series A - PHARMASEAL
—
Mercia Fund Managers Logo
Mercia Fund Managers
—
Series A - PHARMASEAL Logo
Series A - PHARMASEAL
—
Mercia Fund Managers Logo
Mercia Fund Managers
—
Series A - PHARMASEAL Logo
Series A - PHARMASEAL
—
Mercia Fund Managers Logo
Mercia Fund Managers
—
Series A - PHARMASEAL Logo
Series A - PHARMASEAL
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 1 Contacts 6

Employee Profiles

Board Members and Advisors

News

News and Press

News•Sep 26, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 4, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

507
-8.98%
 in past month

IT Spend

$189.3KThis year, PHARMASEAL is projected to spend $189.3K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Next Flight Out (NFO) Logo
Next Flight Out (NFO)
78

Actively Used Products

18PHARMASEAL uses 18 technology products and services including HTML5, DigiCert, and  Google Compute Engine, according to G2 Stack.

Active Website Tech Count

51PHARMASEAL is actively using 51 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

4PHARMASEAL has registered 4 trademarks with the most popular class being 'Scientific and electric apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is PHARMASEAL's headquarters? PHARMASEAL is located in Nottingham, Nottingham, United Kingdom.Who invested in PHARMASEAL? PHARMASEAL has 3 investors including Mercia Fund Managers and  Midlands Engine Investment Fund.When was the last funding round for PHARMASEAL? PHARMASEAL closed its last funding round on
obfuscation
from a Equity Crowdfunding round.Who are PHARMASEAL's competitors? Alternatives and possible competitors to PHARMASEAL may include Verily, Oracle, and  IQVIA.How much funding has PHARMASEAL raised to date? PHARMASEAL has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|